Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “OligoProgressive Metastatic Disease”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Early research (Phase 1)Not Yet RecruitingNCT07619599
What this trial is testing

A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainOligoprogressive Lung Non-Small Cell Carcinoma+1 more
City of Hope Medical Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT04974671
What this trial is testing

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaMetastatic Renal Cell CarcinomaOligoprogressive+1 more
Yale University 30
Large-scale testing (Phase 3)Looking for participantsNCT06523673
What this trial is testing

Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Non-Small Cell Lung CancerNSCLC Stage IVOligoProgressive Metastatic Disease
Second Affiliated Hospital, School of Medicine, Zhejiang University 104
Not applicableNot Yet RecruitingNCT06882499
What this trial is testing

Stereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer II

Who this might be right for
Breast Cancer, MetastaticMetastatic Breast Cancer
Peter MacCallum Cancer Centre, Australia 74
Testing effectiveness (Phase 2)Looking for participantsNCT04989725
What this trial is testing

Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer

Who this might be right for
Head and Neck CancerMetastatic CancerOligoprogressive
Centre hospitalier de l'Université de Montréal (CHUM) 46
Large-scale testing (Phase 3)Active Not RecruitingNCT07076693
What this trial is testing

Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）

Who this might be right for
OligoProgressive Metastatic DiseaseNon-Small Cell Lung Cancer
Shanghai Chest Hospital 97
Large-scale testing (Phase 3)Looking for participantsNCT06367972
What this trial is testing

Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)

Who this might be right for
OligoProgressive Metastatic Disease
M.D. Anderson Cancer Center 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT03808662
What this trial is testing

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

Who this might be right for
TNBC - Triple-Negative Breast CancerTriple Negative Breast CancerNSCLC+4 more
Memorial Sloan Kettering Cancer Center 107
Not applicableLooking for participantsNCT06925984
What this trial is testing

Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)

Who this might be right for
OligoProgressive Metastatic Disease
Jules Bordet Institute 48
Testing effectiveness (Phase 2)Looking for participantsNCT05301881
What this trial is testing

COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study

Who this might be right for
Breast Cancer InvasiveMetastatic CancerOligoprogressive
The Netherlands Cancer Institute 118
Testing effectiveness (Phase 2)Looking for participantsNCT07038304
What this trial is testing

The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer (Adenocarcinoma)OligoProgressive Metastatic DiseaseCastration Resistant Metastatic Prostate Cancer+1 more
University Medical Center Groningen 35
Not applicableActive Not RecruitingNCT04624828
What this trial is testing

Immune Response Evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer Patients Treated With SBRT

Who this might be right for
Oligorecurrent and Oligoprogressive Prostate Cancer Patients
Istituto Clinico Humanitas 40
Testing effectiveness (Phase 2)Looking for participantsNCT06601296
What this trial is testing

Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer

Who this might be right for
Metastatic Renal Cell Carcinoma ( mRCC)OligoProgressive Metastatic Disease
University of Texas Southwestern Medical Center 15
Testing effectiveness (Phase 2)Looking for participantsNCT06260033
What this trial is testing

Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor-Positive Breast CarcinomaMetastatic Breast Carcinoma
City of Hope Medical Center 18
Testing effectiveness (Phase 2)Looking for participantsNCT04299646
What this trial is testing

A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases

Who this might be right for
Metastatic Renal Cell CarcinomaRadiotherapy
Centre Francois Baclesse 77
Not applicableLooking for participantsNCT06055881
What this trial is testing

Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy

Who this might be right for
Breast CarcinomaAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast Cancer
Mayo Clinic 45
Large-scale testing (Phase 3)Looking for participantsNCT06841172
What this trial is testing

Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC

Who this might be right for
OligoProgressive Metastatic DiseaseHepatocellular Carcinoma (HCC)Radiotherapy+1 more
Shandong Cancer Hospital and Institute 132
Not applicableLooking for participantsNCT04115254
What this trial is testing

Stereotactic Magnetic Resonance Guided Radiation Therapy

Who this might be right for
Pancreas CancerLung CancerRenal Cancer+10 more
Dana-Farber Cancer Institute 397
Not applicableNot Yet RecruitingNCT06489821
What this trial is testing

STereotactic Body Radiotherapy (SBRT) for Oligoprogressive Breast Cancer

Who this might be right for
Metastatic Breast CancerOligoprogression
Juravinski Cancer Center 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06813664
What this trial is testing

CtDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI)

Who this might be right for
Metastatic NSCLC - Non-Small Cell Lung CancerOligoProgressive Metastatic Disease
University Health Network, Toronto 60
Load More Results